Literature DB >> 24842894

High protein diet attenuates histopathologic organ damage and vascular leakage in transgenic murine model of sickle cell anemia.

Elizabeth Ann Manci1, Hyacinth I Hyacinth2, Patrice L Capers3, David R Archer4, Sydney Pitts5, Samit Ghosh4, John Patrickson5, Michael E Titford1, Solomon F Ofori-Acquah4, Jacqueline M Hibbert6.   

Abstract

Previous reports have shown that a high protein diet improves weight gain and decreases expression of inflammatory markers in weanling Berkeley transgenic sickle cell mice. The effect of this diet on the underlying histopathology, however, has not been studied. Age-matched, male C57BL/6 controls (n = 24), Berkley sickle mice (n = 31) and Townes sickle mice (n = 14) were randomized in a terminal experiment at weaning to isoenergetic diets, with either normal (20%) or high (35%) amount of energy from protein, by replacing dextrin. Tissue sampling for blinded histologic study and scoring of changes at baseline and after 3 months of feedings showed progressive siderosis and infarcts in spleen, kidney, and liver in all sickle groups, and no significant changes in age- and sex-matched normal controls. High-protein (35%) fed Berkeley sickle mice had significantly fewer (p < 0.01) infarcts in spleen (35.7% less), liver (12.5% less), and kidney (28.6% less) and lower histopathologic scores (p < 0.01) for chronic tissue injury in liver and spleen than matched normal-protein (20%) fed Berkeley sickle mice. In addition, high-protein fed Townes sickle mice had less vascular leakage (∼36%) in the heart, lungs, and brain and a better survival rate (21%) than matched normal-protein Townes sickle mice. This is the first report of histopathologic evidence that a high protein:calorie diet attenuates sickle cell related chronic organ injury in transgenic sickle cell mouse models.
© 2014 by the Society for Experimental Biology and Medicine.

Entities:  

Keywords:  Transgenic mice; histopathology; nutrition; sickle cell anemia; vascular dysfunction

Year:  2014        PMID: 24842894      PMCID: PMC4237702          DOI: 10.1177/1535370214531863

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  26 in total

1.  Comparison of bathophenanthroline sulfonate and ferene as chromogens in colorimetric measurement of low hepatic iron concentration.

Authors:  L Pieroni; L Khalil; F Charlotte; T Poynard; A Piton; B Hainque; F Imbert-Bismut
Journal:  Clin Chem       Date:  2001-11       Impact factor: 8.327

2.  Knockout-transgenic mouse model of sickle cell disease.

Authors:  T M Ryan; D J Ciavatta; T M Townes
Journal:  Science       Date:  1997-10-31       Impact factor: 47.728

3.  Proinflammatory cytokines and the hypermetabolism of children with sickle cell disease.

Authors:  Jacqueline M Hibbert; Lewis L Hsu; Sam J Bhathena; Ikovwa Irune; Bismark Sarfo; Melissa S Creary; Beatrice E Gee; Ali I Mohamed; Iris D Buchanan; Ahmad Al-Mahmoud; Jonathan K Stiles
Journal:  Exp Biol Med (Maywood)       Date:  2005-01

4.  Sickle cell anemia: a potential nutritional approach for a molecular disease.

Authors:  S T Ohnishi; T Ohnishi; G B Ogunmola
Journal:  Nutrition       Date:  2000-05       Impact factor: 4.008

5.  Protein turnover and energy expenditure increase during exogenous nutrient availability in sickle cell disease.

Authors:  M J Borel; M S Buchowski; E A Turner; R E Goldstein; P J Flakoll
Journal:  Am J Clin Nutr       Date:  1998-09       Impact factor: 7.045

6.  TNF-α, IFN-γ, IL-10, and IL-4 levels were elevated in a murine model of human sickle cell anemia maintained on a high protein/calorie diet.

Authors:  Hyacinth I Hyacinth; Patrice L Capers; David R Archer; Jacqueline M Hibbert
Journal:  Exp Biol Med (Maywood)       Date:  2013-11-26

7.  Arginine therapy of transgenic-knockout sickle mice improves microvascular function by reducing non-nitric oxide vasodilators, hemolysis, and oxidative stress.

Authors:  Dhananjay K Kaul; Xiaoqin Zhang; Trisha Dasgupta; Mary E Fabry
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-02       Impact factor: 4.733

Review 8.  Immunological effects of zinc deficiency in sickle cell anemia (SCA).

Authors:  A S Prasad; J Kaplan; G J Brewer; M Dardenne
Journal:  Prog Clin Biol Res       Date:  1989

9.  The Role of Nutrition in Sickle Cell Disease.

Authors:  H I Hyacinth; B E Gee; J M Hibbert
Journal:  Nutr Metab Insights       Date:  2010-01-01

10.  Spatiotemporal dysfunction of the vascular permeability barrier in transgenic mice with sickle cell disease.

Authors:  Samit Ghosh; Fang Tan; Solomon F Ofori-Acquah
Journal:  Anemia       Date:  2012-06-12
View more
  6 in total

1.  Diet and gender influence survival of transgenic Berkley sickle cell mice.

Authors:  Om B Jahagirdar; Aditya M Mittal; Waogwende L Song-Naba; Ritu Jha; Stacy B Kiven; Susan T Thompson; John E Connett; Kalpna Gupta
Journal:  Haematologica       Date:  2019-02-14       Impact factor: 9.941

Review 2.  Integrative approaches to treating pain in sickle cell disease: Pre-clinical and clinical evidence.

Authors:  Varun Sagi; Donovan A Argueta; Stacy Kiven; Kalpna Gupta
Journal:  Complement Ther Med       Date:  2020-05-11       Impact factor: 2.446

3.  Higher prevalence of spontaneous cerebral vasculopathy and cerebral infarcts in a mouse model of sickle cell disease.

Authors:  Hyacinth I Hyacinth; Courtney L Sugihara; Thomas L Spencer; David R Archer; Andy Y Shih
Journal:  J Cereb Blood Flow Metab       Date:  2017-09-19       Impact factor: 6.200

4.  Diet and companionship modulate pain via a serotonergic mechanism.

Authors:  Huy Tran; Varun Sagi; Sarita Jarrett; Elise F Palzer; Rajendra D Badgaiyan; Kalpna Gupta
Journal:  Sci Rep       Date:  2021-02-01       Impact factor: 4.379

5.  Role of age and neuroinflammation in the mechanism of cognitive deficits in sickle cell disease.

Authors:  Raven A Hardy; Noor Abi Rached; Jayre A Jones; David R Archer; Hyacinth I Hyacinth
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-22

6.  Ready-to-use food supplement, with or without arginine and citrulline, with daily chloroquine in Tanzanian children with sickle-cell disease: a double-blind, random order crossover trial.

Authors:  Sharon E Cox; Elizabeth A Ellins; Alphonce I Marealle; Charles R Newton; Deogratias Soka; Philip Sasi; Gian Luca Di Tanna; William Johnson; Julie Makani; Andrew M Prentice; Julian P Halcox; Fenella J Kirkham
Journal:  Lancet Haematol       Date:  2018-03-13       Impact factor: 30.153

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.